MARY STEED: Open Payments
NPI 1619470143 · SUMTER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,462 in 69 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $313 · 2025 $1,462
Food & beverage: $1,462
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $182 |
| PFIZER INC. | 7 | $149 |
| Novartis Pharmaceuticals Corporation | 7 | $126 |
| Boston Scientific Corporation | 3 | $121 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $105 |
| Novo Nordisk Inc | 4 | $104 |
| BridgeBio Pharma, Inc. | 3 | $89 |
| Alnylam Pharmaceuticals Inc. | 4 | $86 |
| Philips North America LLC | 3 | $85 |
| Merck Sharp & Dohme LLC | 5 | $78 |
Products named: JARDIANCE, VYNDAQEL, CDS - MCT/CEM Monitoring, LifeVest, Wegovy, LEQVIO, Attruby, Event.
Industry payments across SC — which companies pay providers there.
